1-7 of 7
Florence Beckerich
Close
Sort by
Journal Articles

HLA-Matched Related Hematopoietic Stem Cell Transplantation in Adolescents and Adults with Sickle Cell Disease: Comparison of Myeloablative Versus Non Myeloablative Approaches. Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire

Nathalie Dhedin, Florian Chevillon, Martin Castelle, Virginie Lavoipierre, Jean-Hugues Dalle, Loïc Vasseur, Laure Joseph, Florence Beckerich, Nimrod Buchbinder, Tereza Coman, Frederic Garban, Alina Ferster, Nicolas Boissel, Stephanie Nguyen Quoc, Jean-Benoit Arlet, Corinne Pondarré
Journal: Blood
Blood (2021) 138 (Supplement 1): 909.
https://doi.org/10.1182/blood-2021-147052
Published: 2021
Journal Articles

Erythroid Chimerism Measurement As a Predictive Tool of Bone Marrow Transplantation Outcome in Sickle Cell Disease

Nicolas Hebert, Meghan Perkins, Ivan Sloma, Laura Bencheikh, Florence Beckerich, Rabah Redjoul, Stephane Moutereau, France Pirenne, Sébastien Maury, Gonzalo De Luna, Pablo Bartolucci
Journal: Blood
Blood (2021) 138 (Supplement 1): 2028.
https://doi.org/10.1182/blood-2021-144844
Published: 2021
Journal Articles

CloB2A2 Reduced-Intensity Conditioning (RIC) Regimen Prior to Allogeneic Stem Cell Transplantation Provides Significant Better Survival Compared to FB2A2 RIC Regimen in Adults with Acute Myeloid Leukemia (AML): A Study on Behalf of the SFGM-TC

Patrice Chevallier, MD PhD, Myriam Labopin, MD, Regis Peffault de la Tour, MD PhD, Bruno Lioure, MD, Jean-Yves Cahn, Anne Huynh, MD, Didier Blaise, MD PhD, Pascal Turlure, MD, Eric Deconinck, Natacha Maillard, MD, Ibrahim Yakoub-Agha, MD PhD, Gaelle Guillerm, MD, Nathalie Fegueux, MD, Nathalie Contentin, MD, Jacques-Olivier Bay, MD PhD, Florence Beckerich, MD, Jean-Henri Bourhis, MD PhD, Marie Y. Detrait, MD, Stephane Vigouroux, Sylvie François, MD, Faezeh Legrand, MD, Nicole Raus, Thierry Guillaume, MD PhD, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1908.
https://doi.org/10.1182/blood.V126.23.1908.1908
Published: 2015
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Offers Similar Outcome after Myeloablative and Sequential Conditioning Regimen in Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)

Justine Decroocq, Raphael Itzykson, MDPhD, Stéphane Vigouroux, MD, Mauricette Michallet, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Florence Beckerich, MD, Anne Huynh, MD, Felipe Suarez, MD PhD, Patrice Chevallier, MD PhD, Stephanie Nguyen quoc, MD, Bruno Lioure, MD, Laurence Clément, MD, Nathalie Fegueux, MD, Nathalie Contentin, MD, Gaelle Guillerm, MD, Jérôme Cornillon, MD, Martin Carré, MD, Natacha Maillard, MD, Mélanie Mercier, MD, Mohamad Mohty, MD PhD, Yves Beguin, MD PhD, Jean-Henri Bourhis, MD PhD, Amandine Charbonnier, MD, Charlotte Jubert, Charles Dauriac, MD, Jacques-Olivier Bay, MD PhD, Didier Blaise, Eric Deconinck, MD PhD, Nicole Raus, Regis Peffault de la Tour, MD PhD, Nathalie Dhedin, MD
Journal: Blood
Blood (2015) 126 (23): 4367.
https://doi.org/10.1182/blood.V126.23.4367.4367
Published: 2015
Journal Articles

Long-Term Remission (>3 years) after Rituximab Monotherapy Used for Patients with Relapsed Indolent Non-Hodgkin Lymphomas (NHL)

Anne-Sophie Michallet, MD PhD, Florence Beckerich, Fadhela Bouafia-Sauvy, Daniel Espinouse, MD, Gilles Salles, MDPhD, Bertrand Coiffier, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1709.
https://doi.org/10.1182/blood.V124.21.1709.1709
Published: 2014
Journal Articles

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor

Clinical Trials & Observations
Florence Beckerich, Christophe Hézode, Christine Robin, Jean-Louis Beaumont, Eric Gautier, Sébastien Maury, Catherine Cordonnier
Journal: Blood
Blood (2014) 124 (16): 2613–2614.
https://doi.org/10.1182/blood-2014-06-582122
Published: 2014
Journal Articles

A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation

Florence Beckerich, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Adriana Plesa, MD, Valerie Dubois, MD, Isabelle Mollet, Helene Labussiere, MD, Lila Gilis, MD, Sophie Ducastelle, MD, Oriane Le Borgne, CRA, Jeremy Monfray, CRA, Fiorenza Barraco, MD, Isabelle Tigaud, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4639.
https://doi.org/10.1182/blood.V122.21.4639.4639
Published: 2013